BICX BioCorRx Inc.

BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$4.13    OTCQB
As of 01/27/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Care Facilities
Index country:  USA
Country of incorporation:  
IPO date:  09/01/2010
Outstanding shares:  6,699,109
Average volume:  2,421
Market cap:   $27,667,320
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -5.63
PB ratio:   317.69
PS ratio:   486.41
Return on equity:   86.38%
Net income %:   -8,634.48%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy